Lyra TherapeuticsÂ Inc (LYRA) Financials

$0.20

$0.00 (0.00%)

As on 04-Sep-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.40	1.53	1.56	1.36	0.29	--
Cost of Revenue	--	0.47	48.03	1.07	1.00	12.52
Gross Profit	0.40	1.53	1.56	1.36	0.29	-12.52
Operating Expenses	29.95	97.88	68.68	57.67	43.90	9.69
Operating Profit (EBIT)	-31.02	-96.35	-67.12	-56.31	-43.62	-22.21
Other Income	--	--	--	--	--	0.08
Profit before Tax	-28.91	-93.40	-62.62	-55.27	-43.51	-22.13
Provision for Tax	0.01	0.04	0.06	0.01	-1.10	-0.08
Profit after Tax (Net Income)	-28.92	-93.44	-62.68	-55.28	-42.41	-22.13
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-55.28	-43.51	-22.13

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-10.72	11.59	89.42	80.75	34.32	74.49
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	37.30	42.12	33.58	14.74	2.31	1.45
Current Liabilities	9.52	12.63	19.60	14.47	18.25	4.88
Total Liabilities	36.11	66.35	142.60	109.97	54.87	80.83

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	19.84	23.32	37.78	9.14	6.95	4.91
Current Assets	16.27	43.03	104.82	100.83	47.92	75.92
Total Assets	36.11	66.35	142.60	109.97	54.87	80.83
Total Debt*	30.26	34.38	26.88	4.18	1.45	2.44
Net Current Assets	6.75	30.39	85.22	86.36	29.67	71.03

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-28.86	-70.01	-63.30	-43.39	-25.82	-21.14
Cash Flow from Investing Activities	-0.10	80.31	-12.58	-65.01	-3.39	-1.78
Cash from Financing Activities	4.27	8.53	65.69	96.26	0.36	87.70
Net Cash Inflow / Outflow	--	--	--	--	--	64.79

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.86	-1.43	-1.02	-1.74	-3.26	-1.71
Cash EPS ($)	-1.83	-1.43	-1.01	-1.70	-3.18	-1.70
Adjusted Book Value ($)	--	0.18	1.45	2.54	2.64	5.75
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.86	-1.08	-1.03	-1.36	-1.99	-1.63
Free Cash Flow per Share ($)	-1.87	-1.11	-1.05	-1.37	-2.25	-1.77

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-88.28	-115.16	-62.30	-91.60	-75.26	-50.53
ROE (%)	-6,594.98	-184.99	-73.67	-96.08	-77.95	-54.09
ROA (%)	-56.45	-89.43	-49.63	-67.07	-62.51	-46.20
EBIT Margin (%)	-7,425.38	-3,959.13	-4,205.91	-4,034.48	-15,303.51	--
Net Margin (%)	-7,266.08	-6,090.94	-4,023.11	-4,055.61	-14,880.70	-26,984.15
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-0.74	-0.02	0.14	3.78	--	--
EBIT Growth (%)	51.34	7.32	-19.16	-26.08	-96.38	-34.45
Net Profit Growth (%)	69.05	-49.07	-13.39	-30.34	-91.67	-35.70
EPS Growth (%)	-0.30	-0.41	0.41	0.47	-0.91	0.14
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-1.65	-0.14	-5.14	-1.81	-1.34	-6.68
Price / Book Value	-4.46	1.16	3.61	1.24	1.65	1.98
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.14	-0.12	-3.78	-0.12	-0.29	-3.42
Close Price ($)	3.08	10.32	262.00	157.00	218.00	570.00
High Price ($)	37.50	339.50	275.00	409.00	825.00	1,100.00
Low Price ($)	2.84	8.13	93.00	117.50	195.50	438.01
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-2.82	2.97	0.30	0.05	0.04	0.03
Short term debt to equity ratio	-0.45	0.36	0.06	0.04	0.03	0.01
Current Ratio	1.71	3.41	5.35	6.97	2.63	15.54
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	--	--	-104.94	-427.60	-270.84

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	0.01	0.01	0.02	0.00	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	1,671.15	21.85	982.61	738.35	29.04
Cash Conversion Cycle	--	--	--	--	--	--